Montréal, December 17, 2025 – The Canadian Hemophilia Society (CHS) has written to the Provincial/Territorial Ministers of Health (excluding Quebec) to urge them to add etranacogene dezaparvovec (Hemgenix), gene...
Montréal, December 12, 2025 – In a letter dated December 10, the Canadian Hemophilia Society (CHS) urged the Provincial/Territorial Blood Liaison Committee (P/TBLC) to accept the Canadian Blood Services...
Two distinct fellowships will be offered by the CHS to allow community members to attend the upcoming World Federation of Hemophilia World Congress taking place in Kuala Lumpur, Malaysia,...